500 related articles for article (PubMed ID: 29048427)
1. HDAC6 inhibition by tubastatin A is protective against oxidative stress in a photoreceptor cell line and restores visual function in a zebrafish model of inherited blindness.
Leyk J; Daly C; Janssen-Bienhold U; Kennedy BN; Richter-Landsberg C
Cell Death Dis; 2017 Aug; 8(8):e3028. PubMed ID: 29048427
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of HDAC6 modifies tau inclusion body formation and impairs autophagic clearance.
Leyk J; Goldbaum O; Noack M; Richter-Landsberg C
J Mol Neurosci; 2015 Apr; 55(4):1031-46. PubMed ID: 25434725
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
[TBL] [Abstract][Full Text] [Related]
4. HDAC6 inhibition results in tau acetylation and modulates tau phosphorylation and degradation in oligodendrocytes.
Noack M; Leyk J; Richter-Landsberg C
Glia; 2014 Apr; 62(4):535-47. PubMed ID: 24464872
[TBL] [Abstract][Full Text] [Related]
5. Selective HDAC6 inhibition prevents TNF-α-induced lung endothelial cell barrier disruption and endotoxin-induced pulmonary edema.
Yu J; Ma Z; Shetty S; Ma M; Fu J
Am J Physiol Lung Cell Mol Physiol; 2016 Jul; 311(1):L39-47. PubMed ID: 27190059
[TBL] [Abstract][Full Text] [Related]
6. MeCP2 deficiency is associated with reduced levels of tubulin acetylation and can be restored using HDAC6 inhibitors.
Gold WA; Lacina TA; Cantrill LC; Christodoulou J
J Mol Med (Berl); 2015 Jan; 93(1):63-72. PubMed ID: 25209898
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 6 inhibitor tubastatin A attenuates angiotensin II-induced hypertension by preventing cystathionine γ-lyase protein degradation.
Chi Z; Byeon HE; Seo E; Nguyen QT; Lee W; Jeong Y; Choi J; Pandey D; Berkowitz DE; Kim JH; Lee SY
Pharmacol Res; 2019 Aug; 146():104281. PubMed ID: 31125601
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HDAC6 increases acetylation of peroxiredoxin1/2 and ameliorates 6-OHDA induced dopaminergic injury.
Jian W; Wei X; Chen L; Wang Z; Sun Y; Zhu S; Lou H; Yan S; Li X; Zhou J; Zhang B
Neurosci Lett; 2017 Sep; 658():114-120. PubMed ID: 28823893
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of histone deacetylase reduces lipopolysaccharide-induced-inflammation in primary mammary epithelial cells by regulating ROS-NF-кB signaling pathways.
Wang J; Zhao L; Wei Z; Zhang X; Wang Y; Li F; Fu Y; Liu B
Int Immunopharmacol; 2018 Mar; 56():230-234. PubMed ID: 29414656
[TBL] [Abstract][Full Text] [Related]
10. HDAC6 inhibition protects cardiomyocytes against doxorubicin-induced acute damage by improving α-tubulin acetylation.
Song R; Yang Y; Lei H; Wang G; Huang Y; Xue W; Wang Y; Yao L; Zhu Y
J Mol Cell Cardiol; 2018 Nov; 124():58-69. PubMed ID: 30315806
[TBL] [Abstract][Full Text] [Related]
11. Involvement of HDAC6 in ischaemia and reperfusion-induced rat retinal injury.
Yuan H; Li H; Yu P; Fan Q; Zhang X; Huang W; Shen J; Cui Y; Zhou W
BMC Ophthalmol; 2018 Nov; 18(1):300. PubMed ID: 30453928
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of HDAC6 by tubastatin A disrupts mouse oocyte meiosis via regulating histone modifications and mRNA expression.
Sui L; Huang R; Yu H; Zhang S; Li Z
J Cell Physiol; 2020 Oct; 235(10):7030-7042. PubMed ID: 32017059
[TBL] [Abstract][Full Text] [Related]
13. SAHA is neuroprotective in in vitro and in situ models of retinitis pigmentosa.
Perron NR; Nasarre C; Bandyopadhyay M; Beeson CC; Rohrer B
Mol Vis; 2021; 27():151-160. PubMed ID: 33907370
[TBL] [Abstract][Full Text] [Related]
14. HDAC6 inhibition induces the failure of mouse early embryonic development.
Wang H; Ling L; Ai L; Bai L
J Cell Physiol; 2019 Jun; 234(6):8752-8759. PubMed ID: 30370558
[TBL] [Abstract][Full Text] [Related]
15. Involvement of transcription factor XBP1s in the resistance of HDAC6 inhibitor Tubastatin A to superoxidation via acetylation-mediated proteasomal degradation.
Zhang Y; Liu CM; Cao XC; Zang Y; Zhou YB; Li J
Biochem Biophys Res Commun; 2014 Jul; 450(1):433-9. PubMed ID: 24909686
[TBL] [Abstract][Full Text] [Related]
16. Blockade of histone deacetylase 6 protects against cisplatin-induced acute kidney injury.
Tang J; Shi Y; Liu N; Xu L; Zang X; Li P; Zhang J; Zheng X; Qiu A; Zhuang S
Clin Sci (Lond); 2018 Feb; 132(3):339-359. PubMed ID: 29358506
[TBL] [Abstract][Full Text] [Related]
17. Activation of histone deacetylase-6 induces contractile dysfunction through derailment of α-tubulin proteostasis in experimental and human atrial fibrillation.
Zhang D; Wu CT; Qi X; Meijering RA; Hoogstra-Berends F; Tadevosyan A; Cubukcuoglu Deniz G; Durdu S; Akar AR; Sibon OC; Nattel S; Henning RH; Brundel BJ
Circulation; 2014 Jan; 129(3):346-58. PubMed ID: 24146251
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HDAC6 deacetylase activity increases its binding with microtubules and suppresses microtubule dynamic instability in MCF-7 cells.
Asthana J; Kapoor S; Mohan R; Panda D
J Biol Chem; 2013 Aug; 288(31):22516-26. PubMed ID: 23798680
[TBL] [Abstract][Full Text] [Related]
19. Silence of HDAC6 suppressed esophageal squamous cell carcinoma proliferation and migration by disrupting chaperone function of HSP90.
Tao H; Chen YY; Sun ZW; Chen HL; Chen M
J Cell Biochem; 2018 Aug; 119(8):6623-6632. PubMed ID: 29665050
[TBL] [Abstract][Full Text] [Related]
20. Selective inhibitor of histone deacetylase 6 (tubastatin A) suppresses proliferation of hepatitis C virus replicon in culture of human hepatocytes.
Kozlov MV; Kleymenova AA; Konduktorov KA; Malikova AZ; Kochetkov SN
Biochemistry (Mosc); 2014 Jul; 79(7):637-42. PubMed ID: 25108326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
